Table 2.
Parameter | TLR4+/+ | TLR4−/− | ||||||
---|---|---|---|---|---|---|---|---|
Sham | Unx | Sham | Unx | |||||
Nondiabetic | Diabetic | Nondiabetic | Diabetic | Nondiabetic | Diabetic | Nondiabetic | Diabetic | |
Body weight (g) | ||||||||
baseline | 22.0±0.8 | 23.7±1.2 | 23.2±0.8 | 23.6±1.8 | 23.9±2.2 | 23.8±1.3 | 23.6±2.5 | 22.4±0.9 |
12 weeks | 30.9±2.4 | 25.5±1.5 | 29.7±1.7 | 24.9±1.9 | 29.2±2.1 | 25.9±1.5 | 28.1±1.9 | 24.8±2.8 |
Blood glucose (mM) | ||||||||
baseline | 6.9±1.3 | 6.1±0.8 | 7.2±1.4 | 6.6±0.8 | 7.0±1.2 | 6.4±1.5 | 6.9±1.5 | 7.4±1.3 |
12 weeks | 6.8±1.2 | 22.7±4.8a | 6.6±1.3 | 23.1±3.5a | 7.2±1.0 | 22.1±3.4a | 6.8±0.8 | 22.4±6.6a |
UACR (μg/mg) | ||||||||
baseline | 40.5±5.7 | 35.6±16.5 | 27.1±9.1 | 33.7±29.4 | 34.5±11.2 | 34.1±10.9 | 26.6±9.2 | 43.2±11.3 |
12 weeks | 38.8±12.6 | 122.8±40.7a | 34.0±5.2 | 389.3±152.4a,b | 41.7±8.6 | 66.2±19.6 | 35.8±9.3 | 86.0±29.4a,c |
Scr (mg/dl) | ||||||||
baseline | 0.14±0.05 | 0.16±0.05 | 0.17±0.05 | 0.13±0.03 | 0.15±0.06 | 0.16±0.08 | 0.17±0.09 | 0.16±0.09 |
12 weeks | 0.17±0.03 | 0.15±0.07 | 0.17±0.09 | 0.32±0.11a,b | 0.14±0.03 | 0.16±0.07 | 0.16±0.03 | 0.19±0.09c |
Sham, sham operation; Scr, serum creatinine.
P<0.05 versus the corresponding nondiabetic group.
P<0.05 versus the corresponding sham-operated group.
P<0.05 versus the corresponding TLR4+/+ group.